{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:40:41Z","timestamp":1793065241577,"version":"4.5.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jacc.2026.03.029","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:15:22Z","timestamp":1779891322000},"page":"3632-3650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Contemporary Management of Acute Heart Failure"],"prefix":"10.1016","volume":"87","author":[{"given":"Jolie","family":"Bruno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Arrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9200-2729","authenticated-orcid":false,"given":"Guillaume","family":"Baudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Biegus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6362-0253","authenticated-orcid":false,"given":"Biykem","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil\u0117","family":"\u010cerlinskait\u0117-Bajor\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura P.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Hartshorne-Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6304-7557","authenticated-orcid":false,"given":"Neusa","family":"Jessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5871-1804","authenticated-orcid":false,"given":"Peder","family":"Myhre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9298-7871","authenticated-orcid":false,"given":"Matteo","family":"Pagnesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7742-9628","authenticated-orcid":false,"given":"Carolyn","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Novi Yanti","family":"Sari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7732-0887","authenticated-orcid":false,"given":"Gianluigi","family":"Savarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoffer Grundtvig","family":"Skaarup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9157-5648","authenticated-orcid":false,"given":"Aferdita","family":"Spahillari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4910-9336","authenticated-orcid":false,"given":"Jozine M.","family":"ter Maaten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Tolppanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Januzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8715-7753","authenticated-orcid":false,"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jacc.2026.03.029_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cardfail.2024.07.001","article-title":"HF stats 2024: heart failure epidemiology and outcomes statistics an updated 2024 report from the Heart Failure Society of America","volume":"31","author":"Bozkurt","year":"2025","journal-title":"J Card Fail"},{"issue":"6","key":"10.1016\/j.jacc.2026.03.029_bib2","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/ejhf.2143","article-title":"The Heart Failure Association atlas: heart failure epidemiology and management statistics 2019","volume":"23","author":"Seferovi\u0107","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.jacc.2026.03.029_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40364-025-00728-8","article-title":"Global, regional, and national burden of heart failure and its underlying causes, 1990-2021: results from the Global Burden of Disease study 2021","volume":"13","author":"Ran","year":"2025","journal-title":"Biomark Res"},{"issue":"10","key":"10.1016\/j.jacc.2026.03.029_bib4","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jchf.2023.04.017","article-title":"Mortality, outcomes, costs, and use of medicines following a first heart failure hospitalization","volume":"11","author":"Bozkurt","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"6","key":"10.1016\/j.jacc.2026.03.029_bib5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ejhf.566","article-title":"European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions","volume":"18","author":"Crespo-Leiro","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"36","key":"10.1016\/j.jacc.2026.03.029_bib6","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"37","key":"10.1016\/j.jacc.2026.03.029_bib7","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.jacc.2026.03.029_bib8","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.jacc.2026.03.029_bib9","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2023.12.024","article-title":"2024 ACC expert consensus decision pathway for treatment of heart failure with reduced ejection fraction","volume":"83","author":"Maddox","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacc.2026.03.029_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-020-0151-7","article-title":"Acute heart failure","volume":"6","author":"Arrigo","year":"2020","journal-title":"Nat Rev Dis Primer"},{"issue":"2","key":"10.1016\/j.jacc.2026.03.029_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejheart.2008.01.007","article-title":"Fluid overload in acute heart failure\u2014re-distribution and other mechanisms beyond fluid accumulation","volume":"10","author":"Cotter","year":"2008","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.jacc.2026.03.029_bib12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ejhf.289","volume":"17","author":"Mebazaa","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"40","key":"10.1016\/j.jacc.2026.03.029_bib13","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1093\/eurheartj\/ehaf559","article-title":"Acute heart failure in noncardiac surgery","volume":"46","author":"Gualandro","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2026.03.029_bib14","article-title":"Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry","author":"Arrigo","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.jacc.2026.03.029_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ehf2.14857","article-title":"2024 update in heart failure","volume":"12","author":"Beghini","year":"2025","journal-title":"ESC Heart Fail"},{"issue":"5","key":"10.1016\/j.jacc.2026.03.029_bib16","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/ejhf.2848","article-title":"Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society","volume":"25","author":"Tsutsui","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"18","key":"10.1016\/j.jacc.2026.03.029_bib17","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/eurheartj\/ehs191","article-title":"Troponin elevation in patients with heart failure: on behalf of the Third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section","volume":"33","author":"Januzzi","year":"2012","journal-title":"Eur Heart J"},{"issue":"18","key":"10.1016\/j.jacc.2026.03.029_bib18","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"44","key":"10.1016\/j.jacc.2026.03.029_bib19","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1093\/eurheartj\/ehad617","article-title":"Acute heart failure: current pharmacological treatment and perspectives","volume":"44","author":"Deniau","year":"2023","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.jacc.2026.03.029_bib20","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1016\/j.jacc.2017.04.042","article-title":"Time\u2013to\u2013furosemide treatment and mortality in patients hospitalized with acute heart failure","volume":"69","author":"Matsue","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jacc.2026.03.029_bib21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3390\/jcm13020311","article-title":"Decongestion in acute heart failure\u2014time to rethink and standardize current clinical practice?","volume":"13","author":"Bilgeri","year":"2024","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.jacc.2026.03.029_bib22","article-title":"Therapeutic novelties in acute heart failure and practical perspectives","volume":"44","author":"Deniau","year":"2025","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"2","key":"10.1016\/j.jacc.2026.03.029_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion\u2014a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.jacc.2026.03.029_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11897-019-0424-1","article-title":"Diuretic resistance in heart failure","volume":"16","author":"Gupta","year":"2019","journal-title":"Curr Heart Fail Rep"},{"issue":"1","key":"10.1016\/j.jacc.2026.03.029_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10741-019-09851-9","article-title":"Loop diuretic resistance complicating acute heart failure","volume":"25","author":"Cox","year":"2020","journal-title":"Heart Fail Rev"},{"issue":"3","key":"10.1016\/j.jacc.2026.03.029_bib26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jchf.2023.09.029","article-title":"A phenomapping tool and clinical score to identify low diuretic efficiency in acute decompensated heart failure","volume":"12","author":"Segar","year":"2024","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.jacc.2026.03.029_bib27","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ehf2.15069","article-title":"Prevalence and characteristics of upfront diuretic resistance in acute heart failure: the P-Value-AHF study","volume":"12","author":"Baumberger","year":"2025","journal-title":"ESC Heart Fail"},{"issue":"6","key":"10.1016\/j.jacc.2026.03.029_bib28","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ejhf.3632","article-title":"Urinary sodium analysis: the key to effective diuretic titration? European Journal of Heart Failure expert consensus document","volume":"27","author":"Meekers","year":"2025","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.jacc.2026.03.029_bib29","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1038\/s41591-023-02532-z","article-title":"Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial","volume":"29","author":"ter Maaten","year":"2023","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.jacc.2026.03.029_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.15420\/cfr.2017:21:1","article-title":"Optimising heart failure therapies in the acute setting","volume":"4","author":"Arrigo","year":"2018","journal-title":"Card Fail Rev"},{"issue":"6","key":"10.1016\/j.jacc.2026.03.029_bib31","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/ejhf.3673","article-title":"Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"27","author":"Chioncel","year":"2025","journal-title":"Eur J Heart Fail"},{"issue":"10367","key":"10.1016\/j.jacc.2026.03.029_bib32","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jacc.2026.03.029_bib33","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/ejhf.1492","article-title":"Acute heart failure congestion and perfusion status\u2014impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry","volume":"21","author":"Chioncel","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.jacc.2026.03.029_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004644","article-title":"Prognostic significance of creatinine increases during an acute heart failure admission in patients with and without residual congestion: a post hoc analysis of the PROTECT data","volume":"11","author":"Metra","year":"2018","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10.1016\/j.jacc.2026.03.029_bib35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jacc.2024.04.055","article-title":"Effects of rapid up-titration of neurohormonal blockade on effective, sustainable decongestion and outcomes in STRONG-HF","volume":"84","author":"Biegus","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.jacc.2026.03.029_bib36","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2024.01.029","article-title":"Enhanced decongestive therapy in patients with acute heart failure","volume":"83","author":"Cotter","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.jacc.2026.03.029_bib37","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.jacc.2023.03.426","article-title":"Up-titrating treatment after heart failure hospitalization across the spectrum of left ventricular ejection fraction","volume":"81","author":"Pagnesi","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacc.2026.03.029_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/ehac530","article-title":"Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial","volume":"44","author":"Biegus","year":"2023","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.jacc.2026.03.029_bib39","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ejhf.2889","article-title":"Are left ventricular ejection fraction phenotypes meaningful in acute heart failure?","volume":"25","author":"Baudry","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10.1016\/j.jacc.2026.03.029_bib40","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/ejhf.1917","article-title":"Diuretic and renal effects of spironolactone and heart failure hospitalizations: a TOPCAT Americas analysis","volume":"22","author":"Kalogeropoulos","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.jacc.2026.03.029_bib41","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.120.045691","article-title":"Empagliflozin in heart failure: diuretic and cardiorenal effects","volume":"142","author":"Griffin","year":"2020","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jacc.2026.03.029_bib42","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.124.011629","article-title":"Mineralocorticoid receptor antagonists in heart failure: an update","volume":"17","author":"Ferreira","year":"2024","journal-title":"Circ Heart Fail"},{"issue":"16","key":"10.1016\/j.jacc.2026.03.029_bib43","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.jacc.2026.03.029_bib44","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jacc.2026.03.029_bib45","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/ejhf.3646","volume":"27","author":"Rosano","year":"2025","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.jacc.2026.03.029_bib46","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin-neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jacc.2026.03.029_bib47","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/ejhf.1498","article-title":"Initiation of sacubitril\/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study","volume":"21","author":"Wachter","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.jacc.2026.03.029_bib48","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/ejhf.1236","article-title":"Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology","volume":"20","author":"Crespo-Leiro","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/j.jacc.2026.03.029_bib49","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1002\/ejhf.70003","article-title":"Identifying and overcoming barriers to referral in advanced heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC","volume":"27","author":"Baudry","year":"2025","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.jacc.2026.03.029_bib50","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ehf2.14163","article-title":"Frailty interferes with the guideline-directed medical therapy in heart failure patients with reduced ejection fraction","volume":"10","author":"Hamada","year":"2023","journal-title":"ESC Heart Fail"},{"issue":"6","key":"10.1016\/j.jacc.2026.03.029_bib51","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3390\/ph17060711","article-title":"Medication and outcome in older heart failure patients: results from a prospective cohort study","volume":"17","author":"Garay","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.jacc.2026.03.029_bib52","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1253\/circrep.CR-25-0003","article-title":"Effectiveness of guideline-directed medical therapy for acute heart failure with reduced ejection fraction in frail elderly patients with malnutrition","volume":"7","author":"Takaoka","year":"2025","journal-title":"Circ Rep"},{"issue":"2","key":"10.1016\/j.jacc.2026.03.029_bib53","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030514","article-title":"Guideline-directed medical therapy in elderly patients with heart failure with reduced ejection fraction: a cohort study","volume":"10","author":"Seo","year":"2020","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.jacc.2026.03.029_bib54","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/ejhf.2920","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: a sub-analysis of the STRONG-HF randomized clinical trial","volume":"25","author":"Arrigo","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"23","key":"10.1016\/j.jacc.2026.03.029_bib55","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.jacc.2024.02.014","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Ommen","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jacc.2026.03.029_bib56","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.jacc.2026.03.029_bib57","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/ejhf.3423","article-title":"Decongestion in acute heart failure: is it time to change diuretic-centred paradigm?","volume":"26","author":"Biegus","year":"2024","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.jacc.2026.03.029_bib58","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1681\/ASN.0000000000000481","article-title":"Mechanistic differences between torsemide and furosemide","volume":"36","author":"Rao","year":"2025","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.jacc.2026.03.029_bib59","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/ejhf.3265","article-title":"Reduced congestion and improved response to a fluid\/sodium challenge in chronic heart failure patients after initiation of sacubitril\/valsartan: the NATRIUM-HF study","volume":"26","author":"Mebazaa","year":"2024","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.jacc.2026.03.029_bib60","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jchf.2024.08.017","article-title":"Efficacy, safety and mechanistic impact of a heart failure guideline-directed medical therapy clinic","volume":"13","author":"Spahillari","year":"2025","journal-title":"JACC Heart Fail"},{"issue":"6","key":"10.1016\/j.jacc.2026.03.029_bib61","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/CIRCULATIONAHA.124.070228","article-title":"Rapid and intensive guideline-directed medical therapy for heart failure: 5 core principles","volume":"150","author":"Greene","year":"2024","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jacc.2026.03.029_bib62","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.cardfail.2024.12.015","article-title":"Increasing evidence supports the benefits of rapid up-titration of the neurohormonal blockade in HFmrEF\/HFpEF patients with AHF","volume":"31","author":"Cotter","year":"2025","journal-title":"J Card Fail"},{"issue":"3","key":"10.1016\/j.jacc.2026.03.029_bib63","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial","volume":"28","author":"Voors","year":"2022","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jacc.2026.03.029_bib64","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2030183","article-title":"Sotagliflozin in patients with diabetes and recent worsening heart failure","volume":"384","author":"Bhatt","year":"2021","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.jacc.2026.03.029_bib65","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.036998","article-title":"Guideline-directed medical therapy after hospitalization for acute heart failure: insights from the CONNECT-HF","volume":"13","author":"Shoji","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.jacc.2026.03.029_bib66","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cardfail.2024.12.016","article-title":"Acute heart failure: transitioning from symptom-based care to remission","volume":"32","author":"Cotter","year":"2026","journal-title":"J Card Fail"},{"issue":"11","key":"10.1016\/j.jacc.2026.03.029_bib67","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11886-021-01588-y","article-title":"Improving quality of life in heart failure","volume":"23","author":"Freedland","year":"2021","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"10.1016\/j.jacc.2026.03.029_bib68","doi-asserted-by":"crossref","first-page":"156","DOI":"10.5603\/cj.92243","article-title":"Quality of life in heart failure: new data, new drugs and devices","volume":"31","author":"Major","year":"2024","journal-title":"Cardiol J"},{"issue":"4","key":"10.1016\/j.jacc.2026.03.029_bib69","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCULATIONAHA.122.059725","article-title":"Effects of empagliflozin on symptoms, physical limitations, and quality of life in patients hospitalized for acute heart failure: results from the EMPULSE trial","volume":"146","author":"Kosiborod","year":"2022","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jacc.2026.03.029_bib70","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011221","article-title":"Impact of rapid up-titration of guideline-directed medical therapies on quality of life: insights from the STRONG-HF trial","volume":"17","author":"\u010celutkien\u0117","year":"2024","journal-title":"Circ Heart Fail"},{"issue":"40","key":"10.1016\/j.jacc.2026.03.029_bib71","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.jacc.2026.03.029_bib72","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/ejhf.3641","article-title":"Cardiac rhythm devices in heart failure with reduced ejection fraction\u2014role, timing, and optimal use in contemporary practice. European Journal of Heart Failure expert consensus document","volume":"27","author":"Bozkurt","year":"2025","journal-title":"Eur J Heart Fail"},{"issue":"17","key":"10.1016\/j.jacc.2026.03.029_bib73","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJMoa1210356","article-title":"Biventricular pacing for atrioventricular block and systolic dysfunction","volume":"368","author":"Curtis","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jacc.2026.03.029_bib74","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.hrthm.2022.09.019","article-title":"Pacing-induced cardiomyopathy: A systematic review and meta-analysis of definition, prevalence, risk factors, and management","volume":"20","author":"Somma","year":"2023","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1016\/j.jacc.2026.03.029_bib75","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf050","volume":"27","author":"Glikson","year":"2025","journal-title":"Europace"},{"issue":"35","key":"10.1016\/j.jacc.2026.03.029_bib76","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","article-title":"2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy","volume":"42","author":"Glikson","year":"2021","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jacc.2026.03.029_bib77","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCULATIONAHA.121.054034","article-title":"Implantable cardioverter-defibrillator eligibility after initiation of sacubitril\/valsartan in chronic heart failure: insights from PROVE-HF","volume":"144","author":"Felker","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacc.2026.03.029_bib78","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jchf.2022.09.009","article-title":"Prediction of left ventricular ejection fraction change following treatment with sacubitril\/valsartan","volume":"11","author":"Mohebi","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"13","key":"10.1016\/j.jacc.2026.03.029_bib79","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/eurjpc\/zwad151","article-title":"Comprehensive characterization of noncardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry","volume":"30","author":"Chioncel","year":"2023","journal-title":"Eur J Prev Cardiol"},{"issue":"16","key":"10.1016\/j.jacc.2026.03.029_bib80","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.jacc.2026.03.029_bib81","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jacc.2023.08.026","article-title":"Dapagliflozin in patients with heart failure and deterioration in renal function","volume":"82","author":"Chatur","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.jacc.2026.03.029_bib82","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.jchf.2024.03.014","article-title":"Sacubitril\/valsartan in patients with heart failure and deterioration in eGFR to <30 mL\/min per 1.73 m2","volume":"12","author":"Chatur","year":"2024","journal-title":"JACC Heart Fail"},{"issue":"4","key":"10.1016\/j.jacc.2026.03.029_bib83","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ejhf.3549","article-title":"Management of acute decompensated valvular heart disease","volume":"27","author":"L\u00fcsebrink","year":"2025","journal-title":"Eur J Heart Fail"},{"issue":"8 Pt 2","key":"10.1016\/j.jacc.2026.03.029_bib84","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jchf.2023.07.003","article-title":"Aortic valve disease, transcatheter aortic valve replacement, and the heart failure patient: a state of the art review","volume":"11","author":"Okumus","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"21","key":"10.1016\/j.jacc.2026.03.029_bib85","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1161\/CIRCULATIONAHA.122.061693","article-title":"Association between sacubitril\/valsartan initiation and mitral regurgitation severity in heart failure with reduced ejection fraction: the PROVE-HF study","volume":"146","author":"Januzzi","year":"2022","journal-title":"Circulation"},{"issue":"10266","key":"10.1016\/j.jacc.2026.03.029_bib86","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"issue":"10369","key":"10.1016\/j.jacc.2026.03.029_bib87","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous Ferric Derisomaltose in Patients With Heart Failure and Iron Deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet"},{"issue":"48","key":"10.1016\/j.jacc.2026.03.029_bib88","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1093\/eurheartj\/ehad586","article-title":"Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis","volume":"44","author":"Ponikowski","year":"2023","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jacc.2026.03.029_bib89","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ejhf.2810","article-title":"Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis","volume":"25","author":"Graham","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/j.jacc.2026.03.029_bib90","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.jchf.2024.05.014","article-title":"Management of iron deficiency in heart failure","volume":"12","author":"Kido","year":"2024","journal-title":"JACC Heart Fail"},{"issue":"38","key":"10.1016\/j.jacc.2026.03.029_bib91","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1093\/eurheartj\/ehae508","article-title":"Obesity and cardiovascular disease: an ESC clinical consensus statement","volume":"45","author":"Koskinas","year":"2024","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.jacc.2026.03.029_bib92","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cardfail.2025.01.022","article-title":"Efficacy of GLP-1 receptor agonists in patients with heart failure and mildly reduced or preserved ejection fraction: a systematic review and meta-analysis","volume":"31","author":"Waqas","year":"2025","journal-title":"J Card Fail"},{"issue":"5","key":"10.1016\/j.jacc.2026.03.029_bib93","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jchf.2024.12.004","article-title":"Glucagon-like peptide 1 receptor agonist is associated with improved survival in overweight heart failure patients","volume":"13","author":"Karlstr\u00f6m","year":"2025","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.jacc.2026.03.029_bib94","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5334\/gh.1186","article-title":"Access to essential medicines and diagnostic tests for cardiovascular diseases in Maputo City, Mozambique","volume":"18","author":"Jessen","year":"2023","journal-title":"Glob Heart"},{"issue":"4","key":"10.1016\/j.jacc.2026.03.029_bib95","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jacasi.2024.01.013","article-title":"Epidemiology and burden of heart failure in Asia","volume":"4","author":"Feng","year":"2024","journal-title":"JACC Asia"},{"issue":"1","key":"10.1016\/j.jacc.2026.03.029_bib96","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5334\/gh.1449","article-title":"Generating important insights into the spectrum and outcomes of acute heart failure across the african continent: the Sub-Saharan Africa Survey of Heart Failure (THESUS-HF II)","volume":"20","author":"Sliwa","year":"2025","journal-title":"Glob Heart"},{"issue":"5","key":"10.1016\/j.jacc.2026.03.029_bib97","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/ANNALS-24-01926","article-title":"Evaluation and management of chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2024 clinical practice guideline","volume":"178","author":"Madero","year":"2025","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.jacc.2026.03.029_bib98","doi-asserted-by":"crossref","first-page":"693","DOI":"10.7326\/M23-1874","article-title":"Sodium-glucose cotransporter 2 inhibitors and the risk for dialysis and cardiovascular disease in patients with stage 5 chronic kidney disease","volume":"177","author":"Yen","year":"2024","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jacc.2026.03.029_bib99","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1038\/s41598-024-81973-z","article-title":"SGLT2 inhibitors reduce the risk of renal failure in CKD stage 5 patients with type 2 DM","volume":"15","author":"Huang","year":"2025","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jacc.2026.03.029_bib100","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jchf.2023.05.002","article-title":"Nonresponse to heart failure therapy","volume":"11","author":"Bozkurt","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"20","key":"10.1016\/j.jacc.2026.03.029_bib101","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMra1703100","article-title":"Diuretic treatment in heart failure","volume":"377","author":"Ellison","year":"2017","journal-title":"N Engl J Med"},{"issue":"37","key":"10.1016\/j.jacc.2026.03.029_bib102","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1093\/eurheartj\/ehad557","article-title":"Renal function and decongestion with acetazolamide in acute decompensated heart failure: the ADVOR trial","volume":"44","author":"Meekers","year":"2023","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.jacc.2026.03.029_bib103","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/ejhf.3228","article-title":"Renal function and natriuresis-guided diuretic therapy\u2014a pre-specified analysis from the PUSH-AHF trial","volume":"26","author":"Damman","year":"2024","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1016\/j.jacc.2026.03.029_bib104","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jchf.2020.03.009","article-title":"Acute kidney function declines in the context of decongestion in acute decompensated heart failure","volume":"8","author":"McCallum","year":"2020","journal-title":"JACC Heart Fail"},{"issue":"23","key":"10.1016\/j.jacc.2026.03.029_bib105","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/eurheartj\/ehv010","article-title":"The kidney in heart failure: an update","volume":"36","author":"Damman","year":"2015","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jacc.2026.03.029_bib106","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ejhf.2384","article-title":"Worsening renal function in acute heart failure in the context of diuretic response","volume":"24","author":"Emmens","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10.1016\/j.jacc.2026.03.029_bib107","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/CIRCULATIONAHA.121.052792","article-title":"Evidence-based medical therapy in patients with heart failure with reduced ejection fraction and chronic kidney disease","volume":"145","author":"Beldhuis","year":"2022","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jacc.2026.03.029_bib108","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ejhf.2471","article-title":"Renal effects of guideline-directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology","volume":"24","author":"Mullens","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.jacc.2026.03.029_bib109","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jacc.2024.11.014","article-title":"Sodium zirconium cyclosilicate for management of hyperkalemia during spironolactone optimization in patients with heart failure","volume":"85","author":"Kosiborod","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"41","key":"10.1016\/j.jacc.2026.03.029_bib110","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1093\/eurheartj\/ehac401","article-title":"Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial","volume":"43","author":"Butler","year":"2022","journal-title":"Eur Heart J"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2026.03.029_bib111","doi-asserted-by":"crossref","first-page":"i39","DOI":"10.1093\/ckj\/sfad062","article-title":"An update on absolute and relative indications for dialysis treatment modalities","volume":"16","author":"Lambie","year":"2023","journal-title":"Clin Kidney J"},{"issue":"24","key":"10.1016\/j.jacc.2026.03.029_bib112","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jacc.2026.03.029_bib113","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jchf.2018.09.008","article-title":"History of atrial fibrillation and trajectory of decongestion in acute heart failure","volume":"7","author":"Patel","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"10","key":"10.1016\/j.jacc.2026.03.029_bib114","article-title":"Ventricular arrhythmias in acute heart failure: a clinical consensus statement of the Association for Acute CardioVascular Care, the European Heart Rhythm Association, and the Heart Failure Association of the European Society of Cardiology","volume":"26","author":"Gorenek","year":"2024","journal-title":"Euopace"},{"issue":"9961","key":"10.1016\/j.jacc.2026.03.029_bib115","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","article-title":"Efficacy of \u03b2 blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis","volume":"384","author":"Kotecha","year":"2014","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jacc.2026.03.029_bib116","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jacc.2023.12.033","article-title":"Implications of atrial fibrillation for guideline-directed therapy in patients with heart failure","volume":"83","author":"Newman","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jacc.2026.03.029_bib117","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/eurjhf\/hft093","article-title":"Lenient vs strict rate control in patients with atrial fibrillation and heart failure: a post-hoc analysis of the RACE II study","volume":"15","author":"Mulder","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"36","key":"10.1016\/j.jacc.2026.03.029_bib118","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.jacc.2026.03.029_bib119","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/ejhf.2918","volume":"25","author":"Chioncel","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10.1016\/j.jacc.2026.03.029_bib120","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009689","article-title":"Medical therapy for functional mitral regurgitation","volume":"15","author":"Milwidsky","year":"2022","journal-title":"Circ Heart Fail"},{"issue":"8","key":"10.1016\/j.jacc.2026.03.029_bib121","first-page":"912","article-title":"Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure","volume":"111","author":"Pagnesi","year":"2022","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"issue":"7","key":"10.1016\/j.jacc.2026.03.029_bib122","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109726057955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109726057955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T20:26:41Z","timestamp":1786393601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109726057955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":122,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0735109726057955"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2026.03.029","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary Management of Acute Heart Failure","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2026.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 the American College of Cardiology Foundation. Published by Elsevier. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}